热门资讯> 正文
Decoy Therapeutics获得350万美元PIPE融资;股价飙升
2026-06-29 21:09
- Invesco SteelPath业主有限合伙与能源设备主动型ETF(PIPE) 0
- SALARIUS PHARMACEUTICALS(SLRX) 0
- Decoy Therapeutics Inc.(DCOY) 0
- Decoy Therapeutics (DCOY) entered into a $3.5M PIPE financing with a single healthcare-focused institutional investor.
- The company will use the net proceeds to advance its lead antiviral candidate into clinical trials.
- The PIPE is priced at $5.91/share, with closing expected on or about June 29, 2026.
- The financing includes milestone-based warrants that could provide up to an additional $17.5M in gross proceeds upon achieving regulatory and clinical milestones.
- The milestone warrants are tied to Phase 1 CTA filing in Europe, Phase 2a trial approval in the UK, and positive Phase 2a trial data.
- DCOY shares up 116% premarket.
More on Salarius Pharmaceuticals
- Decoy Therapeutics Inc. (DCOY) Discusses Corporate Overview and Pipeline Progress in Antiviral Drug Development Transcript
- Seeking Alpha’s Quant Rating on Salarius Pharmaceuticals
- Financial information for Salarius Pharmaceuticals
推荐文章
美股前瞻 | 特朗普称美伊会谈明天召开！纳指期货升逾1%；太空概念股RKLB大涨12%，豪掷80亿美元收购铱星通讯；康卡斯特飙升22%
新股申购 | 6只新股今启招股！基本半导体一手入场费6387.78港元，中国自动驾驶公司MOMENTA-W一手入场费5971.62港元
华盛早报 | 三星、海力士预告1.3万亿美元大规模投资！中国存储重磅利好，苹果寻求购买长鑫存储芯片
iPad、Xbox接连涨价 折射出存储芯片短缺之痛
港股周报 | 阿里巴巴单周重挫15%！一众科网股继续“寻底”；南方两倍做多海力士ETF规模一度超盈富基金
一周IPO | “万元肉签”新股扎堆！下周还有8只新股上市；SK海力士拟以166美元IPO价登陆美股
美股前瞻 | 纳指期货盘前跌超1%，存储概念回调！SpaceX、CoreWeave获纳入获纳入罗素指数；花旗称AI交易仍未终结
一周财经日历 | 美伊谈判6月28日重启；6月大小非农数据重磅来袭；来福谐波、鲟龙科技等8只新股下周上市
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
